Anticoagulation in ischaemic heart disease.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 16844847.
- Also identified by PMC identifier 1861107.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Although treatments with oral anti‐vitamin K agents have become more refined and safer over the years, physicians are reluctant to prescribe these agents for fear they will cause bleeding, particular in patients with ischaemic heart disease
Medical subject headings
- Anticoagulants
- Antifibrinolytic Agents
- Myocardial Ischemia
- Vitamin K